Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Tuspetinib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aptose Receives $10M From Hanmi; Negotiating Future Collaboration
    Aptose Receives $10M From Hanmi; Negotiating Future Collaboration

    30 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/30/2938722/35575/en/Aptose-Receives-10-Million-Through-a-Facility-Agreement-with-Hanmi-Negotiating-Future-Collaboration-Agreement-with-Hanmi-to-Jointly-Develop-Tuspetinib.html

    GLOBENEWSWIRE
    30 Aug 2024
    Share Share
    Aptose Reports Results for the Second Quarter 2024
    Aptose Reports Results for the Second Quarter 2024

    08 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/08/2927451/35575/en/Aptose-Reports-Results-for-the-Second-Quarter-2024.html

    GLOBENEWSWIRE
    08 Aug 2024
    Share Share
    Aptose Presents Tuspetinib Findings At EHA 2024
    Aptose Presents Tuspetinib Findings At EHA 2024

    14 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/14/2898921/35575/en/Aptose-Presents-Tuspetinib-TUS-Clinical-and-Preclinical-Findings-at-European-Hematology-Association-EHA-2024-Hybrid-Congress.html

    GLOBENEWSWIRE
    14 Jun 2024
    Share Share
    Aptose Tuspetinib Data Featured in Oral Presentation
    Aptose Tuspetinib Data Featured in Oral Presentation

    09 Dec 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/12/09/2793449/35575/en/Aptose-Tuspetinib-Clinical-Data-Featured-in-Oral-Presentation-at-the-2023-ASH-Annual-Meeting.html

    GLOBENEWSWIRE
    09 Dec 2023
    Share Share
    Aptose Tuspetinib Clinical Data Selected for Presentation at the 2023 ASH
    Aptose Tuspetinib Clinical Data Selected for Presentation at the 2023 ASH

    02 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/02/2772405/35575/en/Aptose-Tuspetinib-Clinical-Data-Selected-for-Oral-Presentation-at-the-2023-ASH-Annual-Meeting.html

    GLOBENEWSWIRE
    02 Nov 2023
    Share Share
    Aptose Presents Highlights from Webcast Featuring Data on AML Drug Tuspetinib
    Aptose Presents Highlights from Webcast Featuring Data on AML Drug Tuspetinib

    30 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/30/2769327/35575/en/Aptose-Presents-Highlights-from-Clinical-Update-Webcast-Featuring-Latest-Available-Data-on-AML-Drug-Tuspetinib.html

    GLOBENEWSWIRE
    30 Oct 2023
    Share Share